Immunovant (IMVT) Net Equity Issued and Repurchased (2019 - 2026)
Immunovant (IMVT) reported Net Equity Issued and Repurchased of $20.1 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 588.7% from $2.92 million a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunovant's Net Equity Issued and Repurchased came in at $561.37 million, up 24.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $544.19 million, up 20.9% from FY2025.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 246.1% (FY2021 to FY2026).
- By fiscal year, Net Equity Issued and Repurchased came in at $450 million in FY2025 (-4.8%), $472.75 million in FY2024, $657,000 in FY2023 (+409.3%) and $129,000 in FY2022 (-88.2%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$199.87 million in fiscal Q3 2022 and a high of $516.68 million in fiscal Q3 2026.
- Year over year, Net Equity Issued and Repurchased gained in three of the last five quarters, with growth averaging 256.3%.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was fiscal Q1 2027 (growth of 588.7%); the low point was fiscal Q3 2024 (a decline of 95.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Immunovant | 6.97 Bn | 6.97 Bn | - | 20.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.10 Mn |
| Dec 31, 2025 | 516.68 Mn |
| Sep 30, 2025 | 24.60 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 446.12 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 468.60 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 890,000.00 |
| Mar 31, 2023 | -69.84 Mn |
| Dec 31, 2022 | 70.48 Mn |
| Jun 30, 2022 | 21,000.00 |
| Dec 31, 2021 | -199.87 Mn |
| Sep 30, 2021 | 199.91 Mn |
| Jun 30, 2021 | 91,000.00 |
| Mar 31, 2021 | 189,000.00 |
| Dec 31, 2020 | 690,000.00 |
API Access
Immunovant Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();